Skip to content
Screener

Cogent Biosciences, Inc. COGT Increase Decrease In Operating Leases

Increase Decrease In Operating Leases at other companies

RDI
Reading International, Inc.RDI
-$5.61M+0.3%
RDI
Reading International, Inc.RDI
-$5.61M+0.3%
Grow Generation logo
Grow GenerationGRWG
$160K-9.1%
Liquidity Services logo
Liquidity ServicesLQDT
$216K
Liquidity Services logo
Liquidity ServicesLQDT
$216K
Boot Barn Holdings logo
Boot Barn HoldingsBOOT
$18.37M+210%

Other financials

Income statement

See full
Operating income-$103.6M-38.3%
Net income-$97.4M-35.2%
EPS (diluted)-$0.53-1.9%

Balance sheet

See full
Cash & equivalents$241.2M+91.4%
Total debt$15.5M-9.4%
Total equity$607.7M+177%
Total assets$903.0M+218%

Cash flow

See full
Operating cash flow-$86.9M-30.6%
CapEx$449.0K-17.9%
Free cash flow-$87.3M-30.2%

Valuation

See full
Market cap$7.14B+366%
Enterprise value$6.92B+372%

Profitability

See full
Operating margin-1,044.3%
Net margin-950.4%
FCF margin-184.7%

Returns & leverage

See full
Return on equity-85.7%+1.7pp
Debt / equity-0.1×
Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept cogt:IncreaseDecreaseInOperatingLeases.

The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →

Filed
May 5, 2026, 8:21 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205170

FAQ

What is Cogent Biosciences, Inc.'s increase decrease in operating leases?
Cogent Biosciences, Inc. (COGT) reported increase decrease in operating leases of -$422K in Q1 2026.
How has Cogent Biosciences, Inc.'s increase decrease in operating leases changed year-over-year?
Cogent Biosciences, Inc.'s increase decrease in operating leases decreased by 12.2% year-over-year, from -$376K to -$422K.
What is the long-term trend for Cogent Biosciences, Inc.'s increase decrease in operating leases?
Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s increase decrease in operating leases has grown at a -6.5% compound annual growth rate (CAGR), from -$2.05M to -$1.57M.
What does increase decrease in operating leases mean?
Captures the net change in operating lease liabilities resulting from lease payments and the recognition of new lease obligations. This metric is critical for evaluating how lease-related cash outflows impact the company's overall operating cash flow. It provides transparency into the company's fixed commitment obligations for facilities and equipment.

Ask your AI about Cogent Biosciences, Inc.'s increase decrease in operating leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude